Other PCa oncogenic events, such as loss of Pdcd4 or activation of the MNK/eIF4E pathways, have been described to impact cell secretome protein composition affecting and promoting immune evasion and tumor progression [36, 37]. This evidence concerns the gene PDCD4 and neoplasm.